Profile	GDS3514 / 208763_s_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	3678.06	92
GSM325241	Patient no. 1: treated	4220.44	93
GSM325242	Patient no. 9: control	9594.96	97
GSM325243	Patient no. 9: treated	8818.8	96
GSM325244	Patient no. 18: control	2227.58	87
GSM325245	Patient no. 18: treated	2295.05	87
GSM325246	Patient no. 12: control	1708.49	83
GSM325247	Patient no. 12: treated	1738.95	83
GSM325248	Patient no. 3: control	10322.5	97
GSM325249	Patient no. 3: treated	10626	97
GSM325250	Patient no. 7: control	1467.79	81
GSM325251	Patient no. 7: treated	946.099	74
GSM325252	Patient no. 15: control	2485.23	88
GSM325253	Patient no. 15: treated	2202.24	87
GSM325254	Patient no. 4: control	7884.64	96
GSM325255	Patient no. 4: treated	7547.2	96
GSM325256	Patient no. 19: control	536.347	62
GSM325257	Patient no. 19: treated	508.114	62
GSM325258	Patient no. 14: control	630.245	64
GSM325259	Patient no. 14: treated	627.406	63
GSM325260	Patient no. 13: control	281.074	44
GSM325261	Patient no. 13: treated	627.514	63
GSM325262	Patient no. 17: control	5216.47	94
GSM325263	Patient no. 17: treated	5724.51	95
GSM325264	Patient no. 10: control	3629.13	91
GSM325265	Patient no. 10: treated	2442.35	87
GSM325266	Patient no. 5: control	3897.76	92
GSM325267	Patient no. 5: treated	1336.77	79
GSM325268	Patient no. 11: control	6724.34	96
GSM325269	Patient no. 11: treated	2610.69	88
GSM325270	Patient no. 6: control	2742.1	90
GSM325271	Patient no. 6: treated	1117.7	77
GSM325272	Patient no. 8: control	5537.17	95
GSM325273	Patient no. 8: treated	857.473	71
GSM325274	Patient no. 16: control	2521.52	88
GSM325275	Patient no. 16: treated	1800.79	84
GSM325276	Patient no. 2: control	11150.8	98
GSM325277	Patient no. 2: treated	1087.04	76